Commonwealth Equity Services
ANIK icon

Commonwealth Equity Services’s Anika Therapeutics ANIK Stock Holding History

Commonwealth Equity Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,350
Closed -$343K – 2096
2014
Q3 		$343K Buy
+9,350
New +$404K ﹤0.01% 1463

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Commonwealth Equity Services's ANIK Position: Q4 2014 in Review

Commonwealth Equity Services sold out of Anika Therapeutics (ANIK) in Q4 2014, closing a stake of 9,350 shares — an estimated $343K sold.

Commonwealth Equity Services first reported a position in ANIK in Q3 2014 and held it in 1 quarter. The position peaked at $343K in Q3 2014. 160 funds tracked by Wall St. Rank hold ANIK as of Q4 2014.

  • Commonwealth Equity Services reported no remaining Anika Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Commonwealth Equity Services sold 9,350 Anika Therapeutics shares in Q4 2014, an estimated $343K.
  • Commonwealth Equity Services first reported a position in Anika Therapeutics in Q3 2014 and held it in 1 quarter.
  • Commonwealth Equity Services's Anika Therapeutics position peaked at $343K in Q3 2014.
  • 160 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2014.

Based on Commonwealth Equity Services's 13F filing for Q4 2014, filed 13 Jan 2015.